Artificial Intelligence in Colonoscopy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-65
SponsorJagiellonian University

About this trial

Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination. This study aims to evaluate the impact of artificial intelligence on the detection rate of polyps and early stages of colorectal cancer.

Eligibility criteria

Qualifiers

Consent to participate in the study,

Age between 50 and 65 years,

Scheduled outpatient colonoscopy.

Disqualifiers

Previous colonoscopy,

History of colorectal surgery,

Ongoing biological therapy for any indication,

Primary sclerosing cholangitis,

Trial design

Treatments tested in this trial

  • Computer-aided detection (CADe)

Treatment groups

630 Participants
are divided into 2 treatment groups

Sponsors and collaborators